ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1114

Prevalence of Radiographic and Symptomatic Hip Osteoarthritis in an Urban US Population: The Framingham Osteoarthritis Study

Katherine D. Linsenmeyer1, Ali Guermazi2, Kyu-Chan Kim1, David T. Felson3, Mary M. Clancy4 and Steven C. Vlad5, 1Internal Medicine, Boston Medical Center, Boston, MA, 2Radiology, Boston University, Boston, MA, 3Boston University, Boston, MA, 4School of Medicine, Boston University, Boston, MA, 5Clinical Epidemiology, Boston University, Boston, MA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoarthritis - Clinical Aspects

Session Type: Abstract Submissions (ACR)

Background/Purpose: There are few studies of hip osteoarthritis (OA) in the United States and none in the last 35 years that have addressed the prevalence of hip OA in an urban population. Recent estimates from Europe suggest that 2-5% of the population age 50 and over has symptomatic hip OA. Our goal was to assess the prevalence of radiographic and symptomatic hip OA within the Framingham Osteoarthritis cohort.

Methods: We studied the Community sample of the Framingham Osteoarthritis study which was recruited  among those 50-79 years using random digit dialing from the town of Framingham in 2002-2005. As part of this examination standing long-limb radiographs of the lower extremities including the pelvis were obtained using a near horizontal beam. In addition, subjects answered questions regarding the presence and frequency of joint symptoms and indicated on a homunculus whether they had hip joint pain on most days of the previous month.  Two reviewers who received training from an expert musculoskeletal radiologist read all films and verified abnormal ones with the radiologist. Films where both hips were unreadable were excluded. Films were also assessed for Kellgren-Lawrence grade: radiographic OA (ROA) was defined as K/L ≥ 2 (probable joint space narrowing plus an osteophyte ≥ 2). Interobserver kappas were 0.72 between the readers. Persons with a hip replacement were defined as having hip OA in that joint (n=22 subjects). Symptomatic hip OA (SxOA) was defined as radiographic OA with ipsilateral hip pain.

Results: Of 1025 subjects with radiographs, 949 films could be evaluated in both hips. Mean age was 63.5 years (sd 9.0), 56% were women, mean BMI was 27.9 (sd 4.6), 98.1% were white.  16.9% had radiographic hip OA (20.8% of men, 13.8% of women). Of those with ROA, 73.1% were unilateral and 26.9% bilateral. 11.7% of subjects under 65 had ROA (67/571) as compared to 24.7% of subjects 65 and over (93/376). In subjects with BMI < 25, 19.3% (53/276) had ROA; for BMI 25-29.9, 16.3% (66/404) had ROA; for BMI ≥ 30, 15.2% (41/269) had ROA. Both whites and non-whites had similar rates of ROA (16.9%). Of those with ROA, 21.9% had hip joint pain, yielding a SxOA prevalence of  3.7% of the total population (4.3% of men, 3.2% of women).

Conclusion: Around 1/6 of the subjects in this population-based cohort had radiographic evidence of hip OA; 3.7% of men and women had symptomatic OA, an estimate similar to studies from Europe.


Disclosure:

K. D. Linsenmeyer,
None;

A. Guermazi,
None;

K. C. Kim,
None;

D. T. Felson,
None;

M. M. Clancy,
None;

S. C. Vlad,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-of-radiographic-and-symptomatic-hip-osteoarthritis-in-an-urban-us-population-the-framingham-osteoarthritis-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology